Pathophysiology of bone metastases in serologic carcinomas

被引：0
|
作者：
Sauer, G. [1 ]
Barth, T. F. E. [1 ]
Moeller, P. [1 ]
机构：
[1] Univ Ulm Klinikum, Inst Pathol, D-89081 Ulm, Germany
来源：
UROLOGE | 2007年 / 46卷 / 08期
关键词：
bone metastases; renal carcinoma; urothelial carcinoma; prostatic carcinoma;
D O I：
10.1007/s00120-007-1519-y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The skeletal system is the most frequent metastatic site of hematogenous spread of urologic carcinomas. Osseus metastases are classified as osteoneutral, osteolytic, osteoblastic and combinations thereof. Osteolytic metastases lead to bone resorption by activating osteoclasts, while osteoblastic metastases stimulate osteoblasts by paracrine mechanisms. The local osteoblastic effect is associated with secondary systemic bone resorption. The use of bisphosphonates is now an established supportive therapy and newer treatment strategies including targeted intervention in the pathophysiology of bone metastases and radioimmunotherapy are being applied or will be coming soon.
引用
收藏
页码：888 / 890
页数：5
相关论文
共 50 条
  • [21] Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
    Baldessari, Cinzia
    Pipitone, Stefania
    Molinaro, Eleonora
    Cerma, Krisida
    Fanelli, Martina
    Nasso, Cecilia
    Oltrecolli, Marco
    Pirola, Marta
    D'Agostino, Elisa
    Pugliese, Giuseppe
    Cerri, Sara
    Vitale, Maria Giuseppa
    Madeo, Bruno
    Dominici, Massimo
    Sabbatini, Roberto
    CANCERS, 2023, 15 (05)
  • [22] SARCOMA-LIKE BONE METASTASES FROM COLORECTAL CARCINOMAS - A REPORT OF 2 SCAPULAR METASTASES
    SANZARI, R
    PATON, P
    BOUTET, O
    GUASCH, F
    CHARHON, A
    TETE, R
    SEMAINE DES HOPITAUX, 1992, 68 (39): : 1369 - 1373
  • [23] Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas
    Bernier, MO
    Leenhardt, L
    Hoang, C
    Aurengo, A
    Mary, JY
    Menegaux, F
    Enkaoua, E
    Turpin, G
    Chiras, J
    Saillant, G
    Hejblum, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1568 - 1573
  • [24] PROGNOSIS OF VISCERAL AND BONE METASTASES OF DIFFERENTIATED THYROID CARCINOMAS - 24 CASES
    HEIM, M
    SERMENT, G
    FONTAINE, G
    HENRY, JF
    NOUVELLE PRESSE MEDICALE, 1977, 6 (09): : 729 - 732
  • [25] SEROLOGIC MARKERS OF RECURRENCES OF NASOPHARYNGEAL CARCINOMAS
    DEVATHAIRE, F
    SCHWAAB, G
    SANCHOGARNIER, H
    DETHE, G
    BULLETIN DU CANCER, 1988, 75 (07) : 633 - 633
  • [26] Prostate cancer metastases to bone: Pathophysiology, pain management, and the promise of targeted therapy
    Pinski, J
    Dorff, TB
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (06) : 932 - 940
  • [27] Brain metastases: epidemiology and pathophysiology
    Gavrilovic, IT
    Posner, JB
    JOURNAL OF NEURO-ONCOLOGY, 2005, 75 (01) : 5 - 14
  • [28] Brain metastases: epidemiology and pathophysiology
    Igor T. Gavrilovic
    Jerome B. Posner
    Journal of Neuro-Oncology, 2005, 75 : 5 - 14
  • [29] PLASMINOGEN-ACTIVATOR ACTIVITY IN BONE METASTASES OF PROSTATIC CARCINOMAS AS COMPARED TO PRIMARY TUMORS
    KIRCHHEIMER, JC
    PFLUGER, H
    RITSCHL, P
    HIENERT, G
    BINDER, BR
    INVASION & METASTASIS, 1985, 5 (06): : 344 - 355
  • [30] Pathology and pathophysiology of renal cell carcinomas
    Haitel, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 101 - 102
12345